Biotech companies

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.

Avidity Biosciences is a biotech company developing oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC).

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

Collegium Pharmaceutical is a company that develops and provides medicines for pain management and attention deficit hyperactivity disorder.

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.

Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.

MyoKardia is a company that discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.